Nel ASA's Order Book Is Screaming Growth — But the Cash Position Keeps Whispering Caution
Published on 08/09/2026 at 03:51 | Redaktion boerse-global.de
The Norwegian electrolyzer maker Nel ASA finds itself at an unusual crossroads this autumn: its order intake just exploded by 224 percent, yet the company's income statement and cash reserves tell a far more sobering story. That tension — between a pipeline that's suddenly full and a P&L that keeps bleeding — defines the investment case heading into the October 21 third-quarter report.
The Numbers Behind the Divide
Nel's second-quarter 2026 results, released in mid-July, captured the schism perfectly. Revenue slipped 12 percent year over year to 153 million Norwegian kroner, down from 174 million kroner in the same period of 2025. But new orders surged to 230 million kroner, with a stunning 96 percent of that intake coming from the PEM (proton exchange membrane) segment — the business line Nel increasingly views as its most valuable growth engine.
The profitability picture, however, remains under pressure. EBITDA landed at minus 155 million kroner for the quarter, a figure that includes a one-time charge of 70 million kroner tied to a legal settlement with Iwatani Corporation of America, finalized in early June. The company closed the quarter with 1.3 billion kroner in cash — a cushion that buys time, but not indefinitely.
A Stock That's Cheap for a Reason
The market's verdict is already visible in the share price. Nel closed Friday at €0.1994, up 1.63 percent on the day and 2.68 percent for the week. Year to date, the stock is ahead 5.61 percent. But that's still roughly 45 percent below the 52-week high of €0.3655, set in late May, and about 10 percent under its 50-day moving average of €0.2210 — a technical signal that momentum remains weak at best.
Should investors sell immediately? Or is it worth buying Nel ASA?
JPMorgan recently cut its price target on Nel while maintaining a "Neutral" rating, a move that stands out precisely because it came alongside the blockbuster order numbers. The analyst community at large remains skeptical, with a clear majority voting "Sell." The stock's proximity to its 52-week low of €0.1731 suggests investors are pricing in operational weakness — the open question is whether they're also pricing in the recovery.
The Bull Case: PEM Momentum and Cost Cuts
Optimists point to the demand shift toward PEM technology, which carries better margins than traditional alkaline systems. Nel also launched a new generation of its pressurized alkaline electrolyzer platform in May, which management says will lower production costs and improve scalability. If those savings flow through to the income statement, the gap between order intake and revenue recognition could begin to close in coming quarters.
The 1.3 billion kroner cash position gives Nel room to absorb the Iwatani settlement and focus on operations without an immediate need to raise capital. There's also a potential tailwind from EU funding for clean hydrogen projects, in which Nel could participate through partners — though nothing has been confirmed.
Even the chart is showing early, tentative signs of stabilization. StockInvest.us, an automated quantitative rating service, upgraded the stock from "Sell" to "Hold/Accumulate" on August 5. It's a purely mechanical signal with no fundamental weight, but it does reflect the slightly firmer price action of recent weeks.
The Bear Case: Orders Aren't Revenue
The bearish argument is simpler and, in some ways, more compelling: order intake is a statement of intent, not an invoice. Electrolyzer projects routinely take months or even years between booking and delivery. If revenue stays weak while manufacturing, sales, and legal costs keep running, the cash buffer will shrink faster than the order book grows.
Nel ASA at a turning point? This analysis reveals what investors need to know now.
There's also the leadership question. Nel is searching for a new CEO, and that vacuum can delay operational decisions at precisely the moment execution matters most. Add in broader industry uncertainty — hydrogen demand across the sector has been uneven — and the current order surge could prove to be a one-off rather than the start of a sustainable trend.
What to Watch
The third-quarter report on October 21 will provide the first real test of whether the PEM order momentum is translating into actual revenue. If the trend holds and cost reductions from the new alkaline platform begin showing up in the numbers, the path toward gradual margin improvement remains intact — even if profitability is far from guaranteed.
If, on the other hand, projects slip, cash burns faster than orders convert, and the revenue decline deepens, Nel could find itself testing that 52-week low again. The company's ability to close the gap between its booming order book and its struggling income statement will determine which scenario plays out — and the clock is ticking.
Ad
Nel ASA Stock: New Analysis - 9 August
Fresh Nel ASA information released. What's the impact for investors? Our latest independent report examines recent figures and market trends.
